Christoph Grimm - Gynecology

Author Information

Dr. Christoph Grimm is a distinguished researcher affiliated with the Department of Gynecology and Gynecologic Oncology, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria. His work primarily focuses on gynecologic oncology, contributing significantly to the field through extensive research and publications.

Research Contributions

Dr. Grimm has made substantial contributions to gynecologic oncology, with a particular emphasis on ovarian and cervical cancers. His research spans various aspects, including the prognostic factors in vulvar cancer, the efficacy of checkpoint inhibitor therapy in recurrent gynecologic cancers, and the role of tumor molecular profiling in risk reclassification for endometrial cancer patients. Notably, his work also explores innovative treatments and biomarkers, such as the potential of bitter taste receptors in cancer therapy and the impact of nutritional status on ovarian cancer prognosis.

Aliases

C Grimm, C. Grimm, Christoph Grimm

Publication and Citation Metrics

Metric	Value
Citation Count	4664
H-index	38
Paper Count	210

Publications:

The Pretreatment Controlling Nutritional Status Score in Ovarian Cancer: Influence on Prognosis, Surgical Outcome, and Postoperative Complication Rate

DOI: 10.1055/a-1608-1309

Year: 2022

Topical imiquimod compared with conization to treat cervical high-grade squamous intraepithelial lesions: Multicenter, randomized controlled trial.

DOI: 10.1016/j.ygyno.2022.01.033

Year: 2022

Reliability of Tumor Testing Compared to Germline Testing for Detecting BRCA1 and BRCA2 Mutations in Patients with Epithelial Ovarian Cancer

DOI: 10.3390/jpm11070593

Year: 2021

Surgical, Oncological and Obstetric Outcomes After Radical Abdominal Trachelectomy for Early-Stage Cervical Cancer at a Single Tertiary Center.

DOI: 10.21203/RS.3.RS-456708/V1

Year: 2021

Long-term survival in multiresistant metastatic choriocarcinoma after pembrolizumab treatment: A case report

DOI: 10.1016/j.gore.2021.100817

Year: 2021

Overweight as a Favorable Clinical Biomarker for Checkpoint Inhibitor Therapy Response in Recurrent Gynecologic Cancer Patients

DOI: 10.3390/biom11111700

Year: 2021

The Role of Bitter Taste Receptors in Cancer: A Systematic Review

DOI: 10.3390/cancers13235891

Year: 2021

Risk Reclassification of Patients with Endometrial Cancer Based on Tumor Molecular Profiling: First Real World Data

DOI: 10.3390/jpm11010048

Year: 2021

Prognostic factors in patients with vulvar cancer: the VULCAN study

DOI: 10.1136/ijgc-2019-000526

Year: 2020

Molecular Guided Treatments in Gynecologic Oncology: Analysis of a Real‐World Precision Cancer Medicine Platform

DOI: 10.1634/theoncologist.2019-0904

Year: 2020

What is Local Irritation?

Can Diet Influence Vaginal pH?

Can Thiazide Diuretics Affect Menstrual Cycles?

How are antibiotics selected for treating gynecological infections?

What Are the Challenges in Teaching Surgical Techniques?

How Does Originality Impact Patient Care?

Why is this Journal Important?

How to Apply for Expanded Access?

Who is a Demonstrating Surgeon?

How does early diagnosis impact treatment outcomes?

Partnered Content Networks

Relevant Topics